American Society of Hematology)
Despite its recent FDA approval, the CAR T-cell therapy idecabtagene vicleucel (Abecma) is not a cost-effective therapy for multiple myeloma, according to an analysis by the Institute for Clinical and Economic Review. (
Biopharma Dive)
Less-invasive surgery for uterine leiomyomas led to a higher rate of additional surgical procedures within 1 year as compared with hysterectomy. (
Obstetrics & Gynecology)
Gilead Sciences announced full FDA approval of sacituzumab govitecan-hziy (Trodelvy) for metastatic triple-negative breast cancer, following positive results from the phase III ASCENT study.
Adjuvant pembrolizumab (Keytruda) significantly improved disease-free survival versus placebo following surgery for kidney cancer, Merck announced.
Warning About Delaying 2nd Dose of COVID Vaccination
98cool.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 98cool.ca Daily Mail and Mail on Sunday newspapers.
Rain Therapeutics Appoints Richard Bryce, MBChB, as Executive Vice President and Chief Medical Officer
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Diet change may improve survival for leukaemia patients
saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.